Selected article for: "exposure symptom onset and symptom onset"

Author: Ying Wen; Lan Wei; Yuan Li; Xiujuan Tang; Shuo Feng; Kathy Leung; Xiaoliang Wu; Xiong-Fei Pan; Cong Chen; Junjie Xia; Xuan Zou; Tiejian Feng; Shujiang Mei
Title: Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China
  • Document date: 2020_3_23
  • ID: ddq2q1pg_9
    Snippet: Patients were defined as having Wuhan exposure if they were Wuhan residents or visited Wuhan within the past 14 days before symptom onset, and were defined as having Shenzhen exposure if they had not left Shenzhen within the past 14 days before symptom onset, while all others exposed elsewhere were defined as having exposure elsewhere in mainland China other than Wuhan or Shenzhen. Based on the National Guidelines in Diagnosis and Treatment Schem.....
    Document: Patients were defined as having Wuhan exposure if they were Wuhan residents or visited Wuhan within the past 14 days before symptom onset, and were defined as having Shenzhen exposure if they had not left Shenzhen within the past 14 days before symptom onset, while all others exposed elsewhere were defined as having exposure elsewhere in mainland China other than Wuhan or Shenzhen. Based on the National Guidelines in Diagnosis and Treatment Scheme for COVID-19 (9), the seriousness of clinical presentations of COVID-19 cases was categorized as mild, moderate, severe, and critical. Mild cases were those with virological confirmation but without an evidence of having pneumonia. Moderate cases were mild cases at the same time with a diagnosis of pneumonia. Severe was defined when one of the following criteria was met: dyspnea (respiratory frequency≥30/minute); blood oxygen saturation ≤93%; PaO2/FiO2 ratio <300; and/or lung infiltrates >50% within 24-48 hours.

    Search related documents:
    Co phrase search for related documents